|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The combined contraceptive vaginal ring (NuvaRing) and endometrial histology. |
| Bulten J; Grefte J; Siebers B; Dieben T |
| Contraception. 2005;72:362-365. |
| We investigated the effects of NuvaRing on endometrial histology in a 2-year open-label, multicenter trial in 103 |
| premenopausal women aged 18-35 years. Subjects received 26 cycles of treatment, each comprising 3 weeks of ring |
| use followed by a 1-week ring-free period. Endometrial biopsies were taken at baseline, and at cycles 13 (month 12) |
| and 26 (month 24). Normal biopsy results were obtained in all subjects after 24 months of NuvaRing treatment. |
| Atrophic or inactive endometrium and secretory changes were present in the majority of the biopsies after 1 year and |
| 2 years of treatment with the vaginal ring. It was concluded that long-term use of NuvaRing has no adverse effects on |
| endometrial histology. (PubHealth.info Document ID: CONT1T 81-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "The combined contraceptive vaginal ring (NuvaRing) and |
| endometrial histology.", is(are) Bulten J; Grefte J; Siebers B; Dieben T. The source of this article is |
| "Contraception. 2005;72:362-365.". This article was published in 2005 in English language(s). (PubHealth.info® |
| Document ID: CONT1T 81-06. All rights reserved with PubHealth.info) PIN: 81 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |